BR0314481A - Método de produção de uma composição enriquecida com isoquercitrina, composição enriquecida com isoquercitrina e processo para a preparação de uma composição enriquecida com rutina de biomassa que contém rutina - Google Patents

Método de produção de uma composição enriquecida com isoquercitrina, composição enriquecida com isoquercitrina e processo para a preparação de uma composição enriquecida com rutina de biomassa que contém rutina

Info

Publication number
BR0314481A
BR0314481A BR0314481-0A BR0314481A BR0314481A BR 0314481 A BR0314481 A BR 0314481A BR 0314481 A BR0314481 A BR 0314481A BR 0314481 A BR0314481 A BR 0314481A
Authority
BR
Brazil
Prior art keywords
enriched composition
rutin
isoquercitrin
enriched
composition
Prior art date
Application number
BR0314481-0A
Other languages
English (en)
Inventor
Peter R Chang
Alister Muir
Original Assignee
Sua Majestade A Rainha De Dire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sua Majestade A Rainha De Dire filed Critical Sua Majestade A Rainha De Dire
Publication of BR0314481A publication Critical patent/BR0314481A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)

Abstract

"MéTODO DE PRODUçãO DE UMA COMPOSIçãO ENRIQUECIDA COM ISOQUERCITRINA, COMPOSIçãO ENRIQUECIDA COM ISOQUERCITRINA E PROCESSO PARA A PREPARAçãO DE UMA COMPOSIçãO ENRIQUECIDA COM RUTINA DE BIOMASSA QUE CONTéM RUTINA". Trata-se de um processo para a preparação de uma composição enriquecida com rutina de biomassa de planta, o qual compreende a extração com uma solução aquosa e a precipitação. Um preparado de enzima, tal como a naringinase, é utilizado para a transformação da rutina em composições de valor mais elevado que contêm proporções aumentadas de isoquercitrina e quercetina.
BR0314481-0A 2002-09-23 2003-09-23 Método de produção de uma composição enriquecida com isoquercitrina, composição enriquecida com isoquercitrina e processo para a preparação de uma composição enriquecida com rutina de biomassa que contém rutina BR0314481A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41300202P 2002-09-23 2002-09-23
PCT/CA2003/001453 WO2004027074A2 (en) 2002-09-23 2003-09-23 Extraction, purification and conversion of flavonoids from plant biomass

Publications (1)

Publication Number Publication Date
BR0314481A true BR0314481A (pt) 2005-07-26

Family

ID=32030953

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314481-0A BR0314481A (pt) 2002-09-23 2003-09-23 Método de produção de uma composição enriquecida com isoquercitrina, composição enriquecida com isoquercitrina e processo para a preparação de uma composição enriquecida com rutina de biomassa que contém rutina

Country Status (8)

Country Link
US (1) US20060099690A1 (pt)
EP (1) EP1546356A2 (pt)
JP (1) JP2006502712A (pt)
CN (1) CN1685053A (pt)
AU (1) AU2003269646A1 (pt)
BR (1) BR0314481A (pt)
CA (1) CA2496316A1 (pt)
WO (1) WO2004027074A2 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501245B2 (en) * 2000-12-05 2013-08-06 Morinda, Inc. Selectively inhibiting estrogen production and providing estrogenic effects in the human body
US7691425B2 (en) * 2003-09-29 2010-04-06 San-Ei Gen F.F.I., Inc. Method for manufacturing α-glycosylisoquercitrin, intermediate product and by-product thereof
JP4685363B2 (ja) * 2004-03-31 2011-05-18 長田産業株式会社 ケルセチン高濃度含有物の製造方法
US7943190B2 (en) 2005-05-13 2011-05-17 Her Majesty the Queen in Right in Canada as Represented by the Minister of Agriculture and Agri-Food Canada Extraction of phytochemicals
JP2007070265A (ja) * 2005-09-05 2007-03-22 Oriza Yuka Kk 脂質代謝改善用組成物
RU2315593C1 (ru) * 2006-08-02 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Липосомальная композиция антиоксидантов для ингаляций при заболеваниях легких и верхних дыхательных путей
CN101100683B (zh) * 2006-09-08 2010-05-12 颜廷和 一种甙元型黄酮生物转化及纯化的方法
JP4790561B2 (ja) * 2006-10-12 2011-10-12 東洋精糖株式会社 フラボノイド組成物、その製造方法および用途
ITBO20070542A1 (it) * 2007-07-31 2009-02-01 Univ Bologna Alma Mater Metodo per il trattamento di matrici vegetali
US9072717B2 (en) * 2007-09-18 2015-07-07 Elc Management Llc Cosmetic compositions containing alpha glucosidase inhibitors and methods of use
US20100297020A1 (en) * 2008-10-10 2010-11-25 Limerick Biopharma, Inc. Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
CZ302216B6 (cs) * 2009-10-30 2010-12-29 Mikrobiologický ústav AV CR, v. v. i. Zpusob výroby quercetin-3-beta-D-glukopyranosidu za vzniku L-rhamnosy
CN101865834A (zh) * 2010-05-04 2010-10-20 严希海 一种构树根中黄酮含量的测定方法
EP2579886A4 (en) 2010-05-10 2014-05-07 Univ Dalhousie PHENOLIC COMPOSITIONS DERIVED FROM APPLE SKIN AND USES THEREOF
WO2011147028A2 (en) * 2010-05-27 2011-12-01 Her Majesty The Queen In Right Of The Province Of Nova Scotia, As Represented By The Nova Scotia Agricultural College On Behalf Of The Minister Of Agriculture. Apple skin extracts for treating cardiovascular disease
CN101985639B (zh) * 2010-11-16 2013-08-07 江苏科技大学 α-L-鼠李糖苷酶在生物转化芦丁定向合成异槲皮苷中的应用
CN102735782A (zh) * 2011-04-12 2012-10-17 中国科学院长春应用化学研究所 一种筛选α-葡萄糖苷酶抑制剂的方法
CN102382093A (zh) * 2011-12-09 2012-03-21 成都欧康医药有限公司 槲皮素的生产工艺
US11234918B2 (en) 2012-06-06 2022-02-01 Basf Corporation Methods for botanical and/or algae extraction
CN102876746A (zh) * 2012-10-11 2013-01-16 江苏科技大学 离子液体共溶剂效应强化酶促合成异槲皮苷的方法
TR201815897T4 (tr) * 2012-10-22 2018-11-21 Alps Pharmaceuticals Ind Co Ltd Uncaria ellipticanin rutin bakımından zengin özütü ve preparasyon yöntemi.
CN103977015B (zh) * 2014-05-05 2016-10-05 南京瑞菁医药科技有限责任公司 中药毛菊苣降脂活性成分配伍组合物
CN104292282B (zh) * 2014-09-22 2015-11-18 右玉县安德益源生物科技有限公司 一种用双水相法制备高纯度芦丁的方法
CN104292281B (zh) * 2014-09-22 2016-02-24 右玉县安德益源生物科技有限公司 一种集成技术制备高纯度芦丁的方法
CN105906676A (zh) * 2016-05-03 2016-08-31 中国药科大学 异槲皮苷制备方法及其抗哮喘方面的用途
CN106309517A (zh) * 2016-11-19 2017-01-11 青海泰柏特生物科技有限公司 从藜麦籽实中提取富集黄酮苷的方法
KR20190018897A (ko) * 2017-08-16 2019-02-26 서원대학교산학협력단 과일껍질 추출물을 함유하는 기억력 증진 또는 인지기능 장애 예방 및 치료용 조성물
CN107860835A (zh) * 2017-10-23 2018-03-30 鲁东大学 一种提高甜荞麦芽中黄酮类化合物含量的方法
CN109893342B (zh) * 2019-04-08 2020-10-27 佳木斯大学附属第一医院 一种颅脑外伤用敷料及其制备方法
CN110283857A (zh) * 2019-06-18 2019-09-27 南京师范大学 一种基于拟茎点霉细胞发酵生产柚皮素的方法
CN111579701A (zh) * 2020-05-19 2020-08-25 河南科高中标检测技术有限公司 一种亚麻荠种子标准指纹图谱建立方法以及检测芦丁含量的方法
CN111676206B (zh) * 2020-05-20 2022-07-22 江苏科技大学 一种α-L-鼠李糖苷酶的截短突变体及其应用
CN112697899B (zh) * 2020-12-07 2022-04-12 中国药科大学 一种银杏黄酮醇苷的检测方法
CN113439849B (zh) * 2021-06-28 2022-06-21 华南理工大学 一种含有高良姜成分的海洋鱼肽及其制备方法
CN115777935A (zh) * 2022-12-28 2023-03-14 西昌航飞苦荞科技发展有限公司 一种苦荞黄酮浸膏制备苦荞芦丁的方法
CN117229250B (zh) * 2023-11-14 2024-01-26 天津玉健生物工程有限公司 槲皮素的提取和纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2950974A (en) * 1958-05-26 1960-08-30 Rohm & Haas Conversion of flavonoid glycosides
US3382475A (en) * 1966-02-03 1968-05-07 Army Usa Cable connector adaptor
US4132782A (en) * 1977-05-19 1979-01-02 Samuel Bean Method for suppressing herpes simplex virus
JPH0294077A (ja) * 1988-09-30 1990-04-04 Canon Inc 情報記録再生装置
ES2071010T3 (es) * 1989-03-08 1995-06-16 Hayashibara Biochem Lab Preparacion y usos de la rutina de alfa-glicosilo.
JP2898019B2 (ja) * 1989-08-21 1999-05-31 三栄源エフ・エフ・アイ株式会社 水難溶性フラボノイドの溶解方法
JP3134233B2 (ja) * 1991-07-26 2001-02-13 株式会社林原生物化学研究所 α−グリコシル ケルセチンとその製造方法並びに用途
JP3510717B2 (ja) * 1995-09-29 2004-03-29 三栄源エフ・エフ・アイ株式会社 活性酸素・フリーラジカル消去活性を有する飲食品
DE19850029A1 (de) * 1998-10-30 2000-05-04 Merck Patent Gmbh Verfahren zur enzymatischen Spaltung von Rutinosiden
NZ519931A (en) * 2000-01-11 2003-01-31 Biorex Health Ltd Production of an enriched flavonoid aglycone extract from plant material using enzymes
DE10006147A1 (de) * 2000-02-11 2001-08-16 Merck Patent Gmbh Verfahren zur Herstellung von monoglycosidierten Flavonoiden

Also Published As

Publication number Publication date
AU2003269646A1 (en) 2004-04-08
CN1685053A (zh) 2005-10-19
JP2006502712A (ja) 2006-01-26
WO2004027074A3 (en) 2004-09-23
CA2496316A1 (en) 2004-04-01
WO2004027074A2 (en) 2004-04-01
US20060099690A1 (en) 2006-05-11
EP1546356A2 (en) 2005-06-29

Similar Documents

Publication Publication Date Title
BR0314481A (pt) Método de produção de uma composição enriquecida com isoquercitrina, composição enriquecida com isoquercitrina e processo para a preparação de uma composição enriquecida com rutina de biomassa que contém rutina
BR0308639A (pt) Composições, artigo, método para repelir qualquer um ou mais membros do grupo de insetos, processo para a produção de di-hidronepetalactona
BRPI0417892A (pt) composto, uso de um composto e processo de tratamento de sementes
NO20075053L (no) Prosess for fremstilling cellulose sulfat med egenskaper
BR0212654A (pt) Ativação e expansão de células
BR0208863A (pt) Composição, e, método para controlar o crescimento de plantas, para preparar uma formulação granular, solúvel em água, de regulador de crescimento de plantas e para melhorar a utilização de uma formulação sólida de regulador de crescimento de plantas para aplicação por pulverização
BR0316470A (pt) Derivados de 3-amino-piperadina e métodos de preparação
AR045234A1 (es) Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen.
TW200642999A (en) Process for preparing a chlorohydrin
BRPI0519496A2 (pt) processo para preparar um composto ou uma composiÇço, e, composiÇço
BRPI0314133A8 (pt) Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona
WO2004032979A3 (en) Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto
BR9906460A (pt) Sistema de regeneração para videiras e usos do mesmo.
PT1268609E (pt) Processo de preparacao de polialquileniminas funcionalizadas, composicoes que as contem e suas e suas utilizacoes
BR0215936A (pt) Inibidores da alfa-glucosidase a partir de uma fonte natural
BR0210740A (pt) Método de preparação de concentrados de flavonóides
MY139167A (en) A lipase powder composition and a process for preparing an esterified compound by using the same
BR9809316A (pt) Preparação de isoflavonas a partir deleguminosas
WO2004075816A3 (de) Verfahren zur herstellung von flavonoid-haltigen zusammensetzungen und ihre verwendung
BR0212246A (pt) Composição indutora da resistência a doença de planta, método para controlar uma doença de planta, e, processo para a produção de uma composição
BRPI0412119A (pt) processo para a produção de ésteres a partir de epóxidos
BR0212757A (pt) Composição, método para produzir uma composição de fator de crescimento, e, método para tratar um defeito de osso, tendão ou cartilagem
AR069074A1 (es) Modificacion de biosintesis de lignina por supresion con acido nucleico sentido
BR0317665A (pt) 1-alquil-3-aminoindazóis
BR9914811A (pt) Processo para a preparação de derivados de quercetina e isoquercetina

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.